General Information of the Compound
Compound ID
CP0555562
Compound Name
6-[6-(hydroxymethyl)pyrimidin-4-yl]oxy-N-[3-(trifluoromethyl)phenyl]naphthalene-1-carboxamide
    Show/Hide
Synonyms
BFH-772
NVP-BFH-772
    Show/Hide
Structure
Formula
C23H16F3N3O3
Molecular Weight
439.393
Canonical SMILES
OCc1cc(Oc2ccc3c(cccc3c2)C(=O)Nc2cccc(c2)C(F)(F)F)ncn1
    Show/Hide
InChI
InChI=1S/C23H16F3N3O3/c24-23(25,26)15-4-2-5-16(10-15)29-22(31)20-6-1-3-14-9-18(7-8-19(14)20)32-21-11-17(12-30)27-13-28-21/h1-11,13,30H,12H2,(H,29,31)
    Show/Hide
InChIKey
JNLSTLQFDDAULK-UHFFFAOYSA-N
CAS
890128-81-1
Physicochemical Property
logP
5.1855
Rotatable Bonds
5
Heavy Atom Count
32
Polar Areas
84.34
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
32

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 24756034
SID: 49659424
ChEMBL ID
CHEMBL4080062
DrugBank ID
DB16035
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00864, Vascular endothelial growth factor receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000077 Ba/F3 Mus musculus (Mouse)  1
1
IC50 = 1.3 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( BFH-772 )
Drug Name BFH-772
Company Novartis AG
Indication
Psoriasis vulgaris
Phase 2